Top Purchases
The top purchases made by insiders yesterday. Remember, returns and win rates are calculated using the previous purchase trades by the insider.
Chief Financial Officer at Perspective Therapeutics, Inc. ($CATX)
The Chief Financial Officer purchased 25,006 shares at $1.40/share ($35,007.15 total) which increased their vested holdings by 7.9%. The current price is $1.37 (-2.1%). Their median purchase size is $32,501.40 and this is their 1st largest purchase out of 5 all time. (SEC Source)
Historic Returns
1m returns: 10% weighted | 0% median | 50% win rate (2/4)
3m returns: 195% weighted | 103% median | 100% win rate (4/4)
6m returns: 91% weighted | 60% median | 100% win rate (3/3)
1y returns: 27% weighted | 56% median | 67% win rate (2/3)
Note: 1 other insiders also purchased the stock
10% Owner at CARGO Therapeutics, Inc. ($CRGX)
The 10% Owner purchased 294,000 shares at $17.00/share ($5.00M total) which increased their vested holdings by 7.1%. The current price is $18.98 (+11.6%). Their median purchase size is $8.75M and this is their 4th largest purchase out of 4 all time. (SEC Source)
Historic Returns
1m returns: 32% weighted | 23% median | 67% win rate (2/3)
3m returns: 63% weighted | 47% median | 67% win rate (2/3)
6m returns: 60% weighted | 55% median | 100% win rate (2/2)
1y returns: N/A
Director at Perspective Therapeutics, Inc. ($CATX)
The Director purchased 55,000 shares at $1.38/share ($75,900.00 total) which increased their vested holdings by 14.8%. The current price is $1.37 (-0.7%). Their median purchase size is $40,014.00 and this is their 3rd largest purchase out of 7 all time. (SEC Source)
Historic Returns
1m returns: 24% weighted | 21% median | 100% win rate (5/5)
3m returns: 122% weighted | 156% median | 100% win rate (5/5)
6m returns: N/A
1y returns: N/A
Note: 1 other insiders also purchased the stock
Top Sales
The top sales made by insiders yesterday. Remember, returns and win rates are calculated using the previous sell trades by the insider. For sell transactions, “win rate” is the percent of profitable trades. If the “win rate” is low, that means the stock typically falls after the insider sells.
Director at DYNAVAX TECHNOLOGIES CORP ($DVAX)
The Director sold 3,615 shares at $11.93/share ($43,126.95 total) which decreased their vested holdings by 8.9%. The current price is $12.32 (+3.3%). Their median sale size is $43,126.90 and this is their 2nd largest sale out of 3 all time. (SEC Source)
Historic Returns
1m returns: -31% weighted | -20% median | 0% win rate (0/2)
3m returns: -27% weighted | -24% median | 0% win rate (0/2)
6m returns: -35% weighted | -46% median | 0% win rate (0/2)
1y returns: -19% weighted | -31% median | 0% win rate (0/2)
SR. VP & CPDO at Celldex Therapeutics, Inc. ($CLDX)
The SR. VP & CPDO sold 38,597 shares at $33.64/share ($1.30M total) which decreased their vested holdings by 70.0%. The current price is $33.47 (-0.5%). Their median sale size is $187K and this is their 1st largest sale out of 3 all time. (SEC Source)
Historic Returns
1m returns: -14% weighted | -13% median | 0% win rate (0/2)
3m returns: -25% weighted | -24% median | 0% win rate (0/2)
6m returns: -35% weighted | -35% median | 0% win rate (0/2)
1y returns: -15% weighted | -14% median | 50% win rate (1/2)
Note: 3 other insiders also sold the stock
Director at Outset Medical, Inc. ($OM)
The Director sold 38,117 shares at $3.78/share ($144K total) which decreased their vested holdings by 29.5%. The current price is $3.82 (+1.0%). Their median sale size is $64,398.20 and this is their 4th largest sale out of 11 all time. (SEC Source)
Historic Returns
1m returns: 1% weighted | -2% median | 30% win rate (3/10)
3m returns: -13% weighted | -3% median | 30% win rate (3/10)
6m returns: -13% weighted | -8% median | 20% win rate (2/10)
1y returns: -56% weighted | -62% median | 0% win rate (0/10)
Disclaimer: The content provided by InsiderEdge™ is for informational purposes only and does not constitute investment advice, an offer to sell, or a solicitation of an offer to buy any securities. The historical performance noted in this post is not is not indicative of future results. Investing involves risk, including the potential loss of principal. Use the platform at your own risk and consult a financial advisor before making any investment decisions. In partnership with Yellowbrick Investing Inc.
